Načítá se...
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
INTRODUCTION: The introduction of targeted drugs has had a significant impact on the approach to assessing tumour response. These drugs often induce a rapid cytostatic effect associated with a less pronounced and slower tumoural volume reduction, thereby impairing the correlation between the absence...
Uloženo v:
| Vydáno v: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969337/ https://ncbi.nlm.nih.gov/pubmed/27072811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3365-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|